From real patient stories to tips on living well, hear firsthand from people who have faced blood cancer.
We’ve also got the latest research and advocacy news, as well as stories from our wonderful fundraisers and donors. You can subscribe to our e-newsletters and event news here.
Michael Bowen was 33 years old and living in Sydney when one morning, as he was driving to work, he received a phone call that would stop his fast paced life in its tracks. Michael received a diagnosis of chronic myeloid leukaemia (CML). In this conversation, Michael talks about the bouts of depression he came up against and how he was able to overcome these hard times.
Terry Robson-Petch has been living with CML for 20 years.
The greatest unmet need in CML is the ability to predict outcomes at the time of diagnosis according to Dr Naranie Shanmuganathan, a consultant haematologist at Royal Adelaide Hospital and SA Pathology.
Dr Pagani has a vision for a personalised approach to treatment-free remission in CML
Heather Jenkins was one of the first Australians to go on a clinical trial for the first targeted therapy for chronic myeloid leukaemia (CML).
Newly revised optimal care pathways (OCPs) provide best practice information for the treatment and care of people living with acute myeloid leukaemia (AML), and diffuse large B-cell lymphoma (DLBCL) and Hodgkin lymphoma (HL).
Diagnosed with two blood cancers, Nick's world changed instantly. Then transplant complications challenged him in ways he didn't expect.
Leanne Pitman tells us the story of her 'scary' decision to stop her CML treatment.
Professor Susan Branford’s work has underpinned many Australian and internationally significant developments in CML over the last 20 years.
Information on the latest clinical trial.
Dr Susan Branford's research involved assessing people with CML to determine if monitoring the level of disease during therapy using a molecular marker could predict treatment outcome.
Leanne Pitman knew she wasn’t well, but it took seven months before she was finally diagnosed with chronic myeloid leukaemia (CML).
Since receiving a shock CML diagnosis in July 2020, Mel Harris has learnt quickly that the so-called ‘invisible cancer’ can have everyday impacts beyond what many would expect.
The Blood Cancer Taskforce has brought the Australian blood cancer community together to develop the first National Strategic Action Plan for Blood Cancer.
The researcher and haematologist takes us on a deep dive into chronic myeloid leukaemia.
Rona Wall was diagnosed with CML in January 2002 after noticing that a large black bruise on her arm hadn’t healed after six weeks.
Rick Razey changed his prescription to generic imatinib twice – most recently to Cipla Imatinib because profits from this drug are donated to the Leukaemia Foundation.
We spoke to world leader in CML research, Professor Timothy Hughes.
Here is part two of our interview with world leader in CML research, Professor Timothy Hughes.
Elle Halliwell found out she was pregnant in early 2016 – two days after being told she had CML.
